The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177 Lu-PSMA Therapy Between Centers in Brazil and Europe
Lu-PSMA therapy is nearly 3 times slower in Brazil than in Europe. Closing the therapeutic access gap requires targeted investments in radiopharmaceutical supply chains and regulatory efficiency.
Authors
- Carlos Silva (ORCID: https://orcid.org/0000-0002-1549-6833)
- Margaret Masukawa (ORCID: https://orcid.org/0000-0002-4934-9305)
- Pedro Henrique Furst Leite (ORCID: https://orcid.org/0009-0003-4563-6176)
- Juliano J. Cerci
- Stefano Fanti
- Wolfgang P. Fendler
- Enrique E. Estrado Lobato
- Andrea Bascioni
- Marcelo Moreira da Silva
- Denise Ferreira Rodrigues
- Fabio Ghetti
- Ken Herrmann
- Diana Paez
- Walter Ayelet
- Elise Nara Sanfelice
Institutions
- International Atomic Energy Agency (AT)
- Centro Universitário Curitiba (BR)
- Azienda USL di Bologna (IT)
- Essen University Hospital (DE)
- Instituto do Cérebro de Brasília (BR)
- Instituto de Oncologia do Paraná (BR)
- Policlinico Abano Terme (IT)
- West German Heart and Vascular Center Essen (DE)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-08-20
- DOI
- https://doi.org/10.2967/jnumed.126.273029
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00